Director John Freund not standing for re-election at June 6, 2025 Annual Meeting

SUTRO BIOPHARMA, INC.

John Freund, board member since 2014, will not stand for re-election at the Annual Meeting on June 6, 2025.
His term expires following the meeting; no disagreement with company operations, policies, or practices.
Freund will continue to advise management as a consultant after his board term ends.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John Freund

Director

STRO · SUTRO BIOPHARMA, INC.

Effective: 2025-06-06
Filed: April 14, 2025, 7:59 PM ET

John Freund, M.D., a member of the Board of Directors (the “Board”) of Sutro Biopharma, Inc., a Delaware corporation (the “Company”) since 2014, informed the Board of his decision to not stand for re-election to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Freund departed as director at SUTRO BIOPHARMA, INC..

Action: not stand for re-election

Exact text from the filing

John Freund, M.D., a member of the Board of Directors (the “Board”) of Sutro Biopharma, Inc., a Delaware corporation (the “Company”) since 2014, informed the Board of his decision to not stand for re-election to the Board.

View on SEC.gov

SUTRO BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0000950170-25-053733

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.